Blood Donor Day 2023: Experts weigh inĀ
Drug Discovery World
JUNE 14, 2023
One example we are following with anticipation are the two FDA approvals for the first gene therapies for sickle cell disease. Besides looking at donor characteristics, our platform, which we call Excellos 360TM, includes the assessment of metabolic and effector potential of cells, and genetic analysis.
Let's personalize your content